112 related articles for article (PubMed ID: 27389554)
1. Nuclear Survivin as a Prognostic Factor in Squamous-Cell Carcinoma of the Oral Cavity.
Santarelli A; Mascitti M; Rubini C; Bambini F; Giannatempo G; Lo Russo L; Sartini D; Emanuelli M; Procaccini M; Lo Muzio L
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):566-570. PubMed ID: 27389554
[TBL] [Abstract][Full Text] [Related]
2. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
5. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
Liu YM; Huang JH; Feng DY; Guo XC
Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
7. [Expression and correlation of survivin and hsa-miR-542-3p in patients with oral squamous cell carcinoma].
Wu N; Lu Y; Liang JZ
Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):720-724. PubMed ID: 28275798
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of survivin and caspase 3 in oral carcinogenesis.
Poomsawat S; Punyasingh J; Vejchapipat P
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):65-71. PubMed ID: 23531848
[TBL] [Abstract][Full Text] [Related]
9. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation leads to changes in survivin expression in oral mucosa.
Lima CF; Crastechini E; Dos Santos NC; Prado Ribeiro AC; Brandão TB; Castro FCF; Issa JS; Almeida JD
J Oral Pathol Med; 2018 Mar; 47(3):293-298. PubMed ID: 29160903
[TBL] [Abstract][Full Text] [Related]
11. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Troiano G; Guida A; Aquino G; Botti G; Losito NS; Papagerakis S; Pedicillo MC; Ionna F; Longo F; Cantile M; Pennella A; Lo Russo L; Di Gioia G; Mariggiò MA; Lo Muzio L; Pannone G
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205554
[TBL] [Abstract][Full Text] [Related]
12. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
[TBL] [Abstract][Full Text] [Related]
13. Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression.
Lauxen IS; Oliveira MG; Rados PV; Lingen MW; Nör JE; Sant'ana Filho M
Oral Dis; 2014 Apr; 20(3):e76-80. PubMed ID: 23738964
[TBL] [Abstract][Full Text] [Related]
14. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
15. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
Ajithkumar M; Murali CR; Vani NV
J Contemp Dent Pract; 2019 May; 20(5):577-581. PubMed ID: 31316021
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma.
Lin CY; Jeng YM; Chou HY; Hsu HC; Yuan RH; Chiang CP; Kuo MY
J Surg Oncol; 2008 May; 97(6):544-50. PubMed ID: 18297688
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
20. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
